Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sevinc

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
The New Microbiologica|August 7, 2003
The prevalence of hepatitis G virus in cancer patientsN Büyükberber, S Büyükberber, A Kadayifci, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 3, 2013
Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective studyM Bulent Akinci, E Algin, A Inal, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 16, 2011
Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failureN Alkis, U Demirci, M Benekli, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
The New Microbiologica|August 7, 2003
The prevalence of hepatitis G virus in cancer patientsN Büyükberber, S Büyükberber, A Kadayifci, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 3, 2013
Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective studyM Bulent Akinci, E Algin, A Inal, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 16, 2011
Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failureN Alkis, U Demirci, M Benekli, et al.
Pageof 5